New Combined Therapy Helps Extend Lives of Men with Prostate Cancer
Practice-changing research shows that a combination of androgen deprivation therapy— a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years.